Literature DB >> 16199811

A concern that drug companies cannot ignore.

Elizabeth Wager1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16199811      PMCID： PMC1240099          DOI： 10.1177/014107680509801008

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  12 in total

1.  Lessons for research ethics committees.

Authors:  Iain Chalmers
Journal:  Lancet       Date:  2002-01-12       Impact factor: 79.321

2.  Good publication practice for pharmaceutical companies.

Authors:  Elizabeth Wager; Elizabeth A Field; Leni Grossman
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

3.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

Authors:  Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

4.  Medical editors issue guidance on ghost writing.

Authors:  Lynn Eaton
Journal:  BMJ       Date:  2005-04-30

5.  European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications.

Authors:  Adam Jacobs; Elizabeth Wager
Journal:  Curr Med Res Opin       Date:  2005-02       Impact factor: 2.580

6.  A uniform clinical trial registration policy for journals of kidney diseases, dialysis, and transplantation.

Authors:  William Couser; Tilman Drueke; Phillip Halloran; Bertram Kasiske; Saulo Klahr; Peter Morris
Journal:  Transplantation       Date:  2005-04-15       Impact factor: 4.939

7.  Ghost writing initiated by commercial companies.

Authors: 
Journal:  J Gen Intern Med       Date:  2005-06       Impact factor: 5.128

8.  A ghostly crew.

Authors:  D Sharp
Journal:  Lancet       Date:  1998-04-11       Impact factor: 79.321

Review 9.  New drug treatment for Alzheimer's disease: lessons for healthcare policy.

Authors:  D Melzer
Journal:  BMJ       Date:  1998-03-07

10.  Publication: an ethical imperative.

Authors:  J Pearn
Journal:  BMJ       Date:  1995-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.